Comparative Study of Indocyanine Green Fluorescence Imaging in Lung Cancer with Near-Infrared-I/II Windows
Overview
Authors
Affiliations
Background: We compare the application of intravenous indocyanine green (ICG) fluorescence imaging in lung cancer with near-infrared-I (NIR-I) and near-infrared-II (NIR-II) windows.
Methods: From March to December 2022, we enrolled patients who received an intravenous injection of ICG (5 mg/kg) 1 day before the planned lung cancer surgery. The lung cancer nodules were imaged by NIR-I/II fluorescence imaging systems, and the tumor-to-normal-tissue ratio (TNR) was calculated. In addition, the fluorescence intensity and signal-to-background ratio (SBR) of capillary glass tubes containing ICG covered with different thicknesses of lung tissue were measured by NIR-I/II fluorescence imaging systems.
Results: In this study, 102 patients were enrolled, and the mean age was 59.9 ± 9.2 years. A total of 96 (94.1%) and 98 (96.1%) lung nodules were successfully imaged with NIR-I and NIR-II fluorescence, and the TNR of NIR-II was significantly higher than that of NIR-I (3.9 ± 1.3 versus 2.4 ± 0.6, P < 0.001). In multiple linear regression, solid nodules (P < 0.001) and squamous cell carcinoma (P < 0.001) were independent predictors of a higher TNR of NIR-I/II. When capillary glass tubes were covered with lung tissue whose thickness was more than 2 mm, the fluorescence intensity and the SBR of NIR-II were significantly higher than those of NIR-I.
Conclusions: We verified the feasibility of NIR-II fluorescence imaging in intravenous ICG lung cancer imaging for the first time. NIR-II fluorescence can improve the TNR and penetration depth of lung cancer with promising clinical prospects.
Hu D, Zha M, Zheng H, Gao D, Sheng Z Research (Wash D C). 2025; 8():0583.
PMID: 39830366 PMC: 11739436. DOI: 10.34133/research.0583.
Progression in Near-Infrared Fluorescence Imaging Technology for Lung Cancer Management.
Chen X, Li Y, Su J, Zhang L, Liu H Biosensors (Basel). 2024; 14(10).
PMID: 39451714 PMC: 11506746. DOI: 10.3390/bios14100501.
NIR-II light in clinical oncology: opportunities and challenges.
Zhang Z, Du Y, Shi X, Wang K, Qu Q, Liang Q Nat Rev Clin Oncol. 2024; 21(6):449-467.
PMID: 38693335 DOI: 10.1038/s41571-024-00892-0.